SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,117,246 | +73.1% | 50,464 | +63.5% | 0.04% | +68.2% |
| Q2 2023 | $3,533,629 | -15.9% | 30,856 | +1.3% | 0.02% | -15.4% |
| Q1 2023 | $4,199,680 | -44.1% | 30,470 | -47.4% | 0.03% | -36.6% |
| Q4 2022 | $7,507,217 | -31.0% | 57,935 | -41.1% | 0.04% | -25.5% |
| Q3 2022 | $10,878,000 | +15.6% | 98,408 | -21.6% | 0.06% | +37.5% |
| Q2 2022 | $9,409,000 | +2651.2% | 125,518 | +2769.6% | 0.04% | +3900.0% |
| Q1 2022 | $342,000 | +14.8% | 4,374 | +14.0% | 0.00% | -50.0% |
| Q2 2021 | $298,000 | -5.1% | 3,838 | -8.8% | 0.00% | -33.3% |
| Q1 2021 | $314,000 | – | 4,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |